findmyKOL
Clinical trialNCT00625846CompletedPhase 2Interventional

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

SponsorNational Cancer Institute (NCI)Enrollment152Recurrent Thyroid Gland CarcinomaStage III Differentiated Thyroid Gland Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7+7 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia

China
  • Chinese University of Hong Kong-Prince of Wales Hospital

    Shatin, Hong Kong, China

Singapore
  • Johns Hopkins Singapore

    Singapore, Singapore

  • National Cancer Centre

    Singapore, Singapore

  • National University Hospital Singapore

    Singapore, Singapore

Taiwan
  • National Taiwan University Hospital

    Taipei, Taiwan

United States
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

  • University of Colorado Hospital

    Aurora, Colorado, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • University of Iowa/holden Comprehensive Cancer Center

    Iowa City, Iowa, United States

  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

  • Wayne State University/karmanos Cancer Institute

    Detroit, Michigan, United States

  • Fairview Ridges Hospital

    Burnsville, Minnesota, United States

  • Fairview-Southdale Hospital

    Edina, Minnesota, United States

  • Unity Hospital

    Fridley, Minnesota, United States

  • Minnesota Oncology Hematology Pa-Maplewood

    Maplewood, Minnesota, United States

  • Abbott-Northwestern Hospital

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Park Nicollet Clinic - Saint Louis Park

    Saint Louis Park, Minnesota, United States

  • United Hospital

    Saint Paul, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • University of Wisconsin Hospital and Clinics

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Feb 2008
Primary completion
21 Dec 2018
Completion
13 Aug 2019
Last update posted
26 Feb 2020
Registered enrollment
152
Registry id
NCT00625846

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.